arrow
T

Todd M. Pitts

university of colorado
H指数:36
被引数:4,889

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer

Lentz, R.W.; Lang, J.; Pitts, T.M.; Blatchford, P.; Hu, J.; Jordan, K.R.; Van Bokhoven, A.; Bagby, S.M.; Dominguez, A.T.A.; Binns, C.A.; 等. 一种新型CD47阻断联合疗法在难治性微卫星稳定型转移性结直肠癌中的II期临床试验及临床前评估. Cancer Res. Commun. 2025, 5, 2039–2052. [Google Scholar] [CrossRef] [PubMed]

2025-11-011
PRE
Expanding the landscape of oncogenic drivers and treatment options in acral and mucosal melanomas by targeted genomic profiling
2024-07-120
PRE
A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer
2024-06-130
OAAI
Overcoming doxorubicin resistance in triple-negative breast cancer using the class I-targeting HDAC inhibitor bocodepsin/OKI-179 to promote apoptosis

使用I类靶向HDAC抑制剂bocodepsin/OKI-179促进细胞凋亡克服三阴性乳腺癌中的阿霉素耐药性

2024-03-017
OAAI
Cabozantinib sensitizes microsatellite stable colorectal cancer to immune checkpoint blockade by immune modulation in human immune system mouse models

卡博替尼在人类免疫系统小鼠模型中通过免疫调节使微卫星稳定的结直肠癌对免疫检查点阻断敏感

2022-11-079
OAAI
Preclinical Development of the Class-I-Selective Histone Deacetylase Inhibitor OKI-179 for the Treatment of Solid Tumors
2022-03-0412
OA
Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell Phenotypes
2021-03-2923
OAAI